Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B

In Malaysia, co-circulation of CRF01_AE and subtype B has resulted in the emergence of the second generation derivative; CRF33_01B in approximately 20% of its HIV-1 infected individuals. Our objective was to identify possible biological advantages that CRF33_01B possesses over its progenitors. Biolo...

Full description

Bibliographic Details
Main Authors: Lau, Katherine A., Wang, Bin, Miranda-Saksena, Monica, Boadle, Ross, Kamarulzaman, Adeeba, Ng, Kee Peng, Saksena, Nitin K.
Format: Article
Published: Bentham Science Publishers 2010
Subjects:
_version_ 1796945148520693760
author Lau, Katherine A.
Wang, Bin
Miranda-Saksena, Monica
Boadle, Ross
Kamarulzaman, Adeeba
Ng, Kee Peng
Saksena, Nitin K.
author_facet Lau, Katherine A.
Wang, Bin
Miranda-Saksena, Monica
Boadle, Ross
Kamarulzaman, Adeeba
Ng, Kee Peng
Saksena, Nitin K.
author_sort Lau, Katherine A.
collection UM
description In Malaysia, co-circulation of CRF01_AE and subtype B has resulted in the emergence of the second generation derivative; CRF33_01B in approximately 20% of its HIV-1 infected individuals. Our objective was to identify possible biological advantages that CRF33_01B possesses over its progenitors. Biological and molecular comparisons of CRF33_01B against its parental subtypes clearly show that CRF33_01B replicated better in activated whole peripheral blood mononuclear cells (PBMCs) and CD4+ T-lymphocytes, but not monocyte-derived macrophages (MDMs). Also, its acquired fitness was greater than CRF01_AE but not subtype B. Moreover, CRF33_01B has higher rate of apoptotic cell death and syncytia induction compared to subtype B. These adaptive and survival abilities could have been acquired by CRF33_01B due to the incorporation of subtype B fragments into the gag-RT region of its full-length genome. Our studies confirm the previously held belief that HIV-1 strains may harbor enhanced biological fitness upon recombination. We therefore estimate a possible gradual replacement of the current predominance of CRF01_AE, as well as wider dissemination of CRF33_01B, together with the identification of other new CRF01_AE/B inter-subtype recombinants in Malaysia.
first_indexed 2024-03-06T05:12:17Z
format Article
id um.eprints-4568
institution Universiti Malaya
last_indexed 2024-03-06T05:12:17Z
publishDate 2010
publisher Bentham Science Publishers
record_format dspace
spelling um.eprints-45682019-11-11T05:11:30Z http://eprints.um.edu.my/4568/ Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B Lau, Katherine A. Wang, Bin Miranda-Saksena, Monica Boadle, Ross Kamarulzaman, Adeeba Ng, Kee Peng Saksena, Nitin K. R Medicine In Malaysia, co-circulation of CRF01_AE and subtype B has resulted in the emergence of the second generation derivative; CRF33_01B in approximately 20% of its HIV-1 infected individuals. Our objective was to identify possible biological advantages that CRF33_01B possesses over its progenitors. Biological and molecular comparisons of CRF33_01B against its parental subtypes clearly show that CRF33_01B replicated better in activated whole peripheral blood mononuclear cells (PBMCs) and CD4+ T-lymphocytes, but not monocyte-derived macrophages (MDMs). Also, its acquired fitness was greater than CRF01_AE but not subtype B. Moreover, CRF33_01B has higher rate of apoptotic cell death and syncytia induction compared to subtype B. These adaptive and survival abilities could have been acquired by CRF33_01B due to the incorporation of subtype B fragments into the gag-RT region of its full-length genome. Our studies confirm the previously held belief that HIV-1 strains may harbor enhanced biological fitness upon recombination. We therefore estimate a possible gradual replacement of the current predominance of CRF01_AE, as well as wider dissemination of CRF33_01B, together with the identification of other new CRF01_AE/B inter-subtype recombinants in Malaysia. Bentham Science Publishers 2010 Article PeerReviewed Lau, Katherine A. and Wang, Bin and Miranda-Saksena, Monica and Boadle, Ross and Kamarulzaman, Adeeba and Ng, Kee Peng and Saksena, Nitin K. (2010) Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B. Current HIV Research, 8 (3). pp. 259-271. ISSN 1570-162X, DOI https://doi.org/10.2174/157016210791111151 <https://doi.org/10.2174/157016210791111151>. https://doi.org/10.2174/157016210791111151 doi:10.2174/157016210791111151
spellingShingle R Medicine
Lau, Katherine A.
Wang, Bin
Miranda-Saksena, Monica
Boadle, Ross
Kamarulzaman, Adeeba
Ng, Kee Peng
Saksena, Nitin K.
Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title_full Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title_fullStr Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title_full_unstemmed Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title_short Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
title_sort evidence for possible biological advantages of the newly emerging hiv 1 circulating recombinant form from malaysia crf33 01b in comparison to its progenitors crf01 ae and subtype b
topic R Medicine
work_keys_str_mv AT laukatherinea evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT wangbin evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT mirandasaksenamonica evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT boadleross evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT kamarulzamanadeeba evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT ngkeepeng evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb
AT saksenanitink evidenceforpossiblebiologicaladvantagesofthenewlyemerginghiv1circulatingrecombinantformfrommalaysiacrf3301bincomparisontoitsprogenitorscrf01aeandsubtypeb